The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
All content for Transforming Biopharma is the property of ZS and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
‘Patients first, people always’: Science and strategy with Savitri Basavaiah
Transforming Biopharma
26 minutes
2 years ago
‘Patients first, people always’: Science and strategy with Savitri Basavaiah
Savitri Basavaiah, vice president portfolio and commercialization strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson, has a deep background in biopharma. She joins Maria Whitman to talk about the broader challenges of commercial leadership and what the future might look like as pharma reimagines its commercial model. She also discusses what pharma should do next at a moment when the pace of innovation is incredibly fast and the challenges are unprecedented; why a grow...
Transforming Biopharma
The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
